Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Frontiers in Immunology|March 4, 2022
NET Release of Long-Term Surviving NeutrophilsJan Philipp Kolman, Laia Pagerols Raluy, Ingo Müller, et al.
British Journal of Haematology|June 25, 2016
Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patientsHeiko-Manuel Teltschik, Frank Heinzelmann, Bernd Gruhn, et al.
Stem Cells and Development|April 17, 2020
Longtime Outcome After Intraosseous Application of Autologous Mesenchymal Stromal Cells in Pediatric Patients and Young Adults with Avascular Necrosis After Steroid or ChemotherapyMichaela Döring, Torsten Kluba, Karin Melanie Cabanillas Stanchi, et al.
Molecular and Cellular Pediatrics|September 10, 2020
Early clinical course after hematopoietic stem cell transplantation in children with juvenile metachromatic leukodystrophyJudith Beschle, Michaela Döring, Christiane Kehrer, et al.
British Journal of Haematology|March 5, 2014
Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemiaPeter Lang, Heiko-Manuel Teltschik, Tobias Feuchtinger, et al.
International Journal of Phytoremediation|January 13, 2015
Agronomic Practices for Improving Gentle Remediation of Trace Element-Contaminated SoilsPetra Kidd, Michel Mench, Vanessa Álvarez-López, et al.
Science Immunology|February 2, 2024
Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosisXun Li, Tristan Wirtz, Timm Weber, et al.
Journal of Hepatology|May 14, 2013
Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashionBastian Höchst, Frank A Schildberg, Pia Sauerborn, et al.
Stem Cells and Development|March 24, 2022
Hematopoietic Stem Cell Transplantation with Mesenchymal Stromal Cells in Children with Metachromatic LeukodystrophyKarin Melanie Cabanillas Stanchi, Judith Böhringer, Manuel Strölin, et al.
The Journal of Pediatrics|July 2, 2002
Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 gRolf F Maier, Michael Obladen, Ingo Müller-Hansen, et al.
Pageof 13